Rui‐Chao Lin
- Molecular Biology top 5%
- Pharmacology top 0.5%
- Plant Science top 5%
- Complementary and alternative medicine top 0.5%
- Pharmacology top 5%
- Co-authors
- Ying‐Yong ZhaoXian‐Long ChengFeng WeiXu BaiShuang‐Cheng MaYa‐Long FengNosratola D. VaziriShuman Liu
- Topics
- Natural product bioactivities and synthesis (24 papers)Metabolomics and Mass Spectrometry Studies (17 papers)Ginseng Biological Effects and Applications (13 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Rui‐Chao Lin
72 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 2.1k
- Pharmacology 623
- Plant Science 563
- Complementary and alternative medicine 464
- Pharmacology 318
Countries citing papers authored by Rui‐Chao Lin
This map shows the geographic impact of Rui‐Chao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui‐Chao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui‐Chao Lin more than expected).
Fields of papers citing papers by Rui‐Chao Lin
This network shows the impact of papers produced by Rui‐Chao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui‐Chao Lin. The network helps show where Rui‐Chao Lin may publish in the future.
Co-authorship network of co-authors of Rui‐Chao Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Rui‐Chao Lin. A scholar is included among the top collaborators of Rui‐Chao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui‐Chao Lin. Rui‐Chao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 243 | |
| 4 | 14 | |
| 5 | 88 | |
| 6 | 105 | |
| 7 | 55 | |
| 8 | 113 | |
| 9 | 16 | |
| 10 | 93 | |
| 11 | 29 | |
| 12 | 77 | |
| 13 | 72 | |
| 14 | 92 | |
| 15 | 78 | |
| 16 | 73 | |
| 17 | 20 | |
| 18 | 23 | |
| 19 | 51 | |
| 20 | 32 |
About Rui‐Chao Lin
Rui‐Chao Lin is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Biology, having authored 72 papers that have together received 3.3k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (24 papers), Metabolomics and Mass Spectrometry Studies (17 papers) and Ginseng Biological Effects and Applications (13 papers). The work is most often cited by research in Pharmacology (623 citations), Complementary and alternative medicine (464 citations) and Nephrology (309 citations). Rui‐Chao Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ying‐Yong Zhao, Xian‐Long Cheng, Feng Wei, Xu Bai, Shuang‐Cheng Ma, Ya‐Long Feng, Nosratola D. Vaziri, Shuman Liu, Yongmin Zhang and Xinyue Xiao. Their work appears in journals such as PLoS ONE, Kidney International and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.